Showing results (131-140 of 152) with videos related to

Sort By:
Pageof 16
Investigative Ophthalmology & Visual Science|May 31, 2002
An assessment of polymorphonuclear leukocyte rigidity in HIV-infected individuals after immune recoveryDavid T Goldenberg, Gary N Holland, William G Cumberland, et al.
Ophthalmology Science|April 20, 2026
Reduction in Pigment Epithelial Detachment Thickness with Faricimab versus Aflibercept 2 mg during Head-to-Head Dosing in TENAYA/LUCERNEJennifer I Lim, Aude Ambresin, Robert L Avery, et al.
Ophthalmology|April 18, 2026
Reference Standard for Validation of Age-Related Macular Degeneration Screening AlgorithmsAmitha Domalpally, Emily Y Chew, Malvina B Eydelman, et al.
American Journal of Ophthalmology|April 3, 2004
Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials-TAP and VIP report no. 3Jennifer J Arnold, Kevin J Blinder, Neil M Bressler, et al.
Ophthalmology. Retina|February 6, 2025
Anatomic Control with Faricimab versus Aflibercept in the YOSEMITE/RHINE Trials in Diabetic Macular EdemaJennifer I Lim, Manuel J Amador, Dilsher S Dhoot, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|June 7, 2024
Faricimab for neovascular age-related macular degeneration and diabetic macular edema: from preclinical studies to phase 3 outcomesHansjürgen Agostini, Francis Abreu, Caroline R Baumal, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 13, 2005
Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trialMohammad Azab, David S Boyer, Neil M Bressler, et al.
Ophthalmology|February 21, 2024
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2Arshad M Khanani, Aachal Kotecha, Andrew Chang, et al.
Ophthalmology|November 25, 2006
Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema, David J Browning, Adam R Glassman, et al.
Signal Transduction and Targeted Therapy|October 21, 2025
Proliferative diabetic retinopathy subtypes defined by immune defense and endothelial mitochondrial dysfunctionMaximilian A McCann, Basma Baccouche, Yueru Li, et al.
Pageof 16